Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 4

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 37–48 of 391 articles

High impact NewsJun 7, 2026

FDA approves Dupixent for COPD with eosinophilic phenotype

FDA · chronic obstructive pulmonary disease · 6 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

GSK Blenrep wins FDA approval in relapsed multiple myeloma

FDA · blood cancer · 6 min

Dr. Sarah Mitchell
Critical impact AnalysisJun 7, 2026

FDA Approves Vertex’s First-in-Class Non-Opioid Pain Drug Journavx

FDA · moderate-to-severe acute pain · 8 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

FDA approves Keytruda for adjuvant NSCLC treatment, expanding Merck’s lung cancer label

FDA · lung cancer · 6 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

FDA approves Merck’s Keytruda for adjuvant NSCLC treatment

FDA · lung cancer · 8 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

Eli Lilly's donanemab wins FDA approval for early Alzheimer's disease

FDA · Alzheimer's disease · 6 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

FDA approves Keytruda for adjuvant NSCLC, a Merck catalyst

FDA · lung cancer · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 7, 2026

Vertex launches Journavx after FDA approval for acute pain

FDA · oncology · 9 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

FDA approves Keytruda adjuvant NSCLC use in early-stage lung cancer

FDA · oncology · 7 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

FDA approves Keytruda adjuvant NSCLC use: what Merck investors should watch

FDA · oncology · 7 min

Dr. Sarah Mitchell
Critical impact AnalysisJun 7, 2026

Gene Therapy FDA Approval for Rare Disease: Updated List and Analysis

FDA · rare disease · 5 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Exclusive: FDA issues industry-friendly gene therapy guidance: What BD teams need to know

FDA · gene therapy · 4 min

Dr. Sarah Mitchell